“showed a trend”

However, although HbA1c showed a trend toward significance ( P = 0.046), but did not meet the Bonferroni-adjusted threshold ( P > 0.025).

SASH1 expression showed a trend toward association with prognosis ( P = 0.0463), with the low-expression group exhibiting lower survival probability, suggesting SASH1 as a potential favorable prognostic marker, though further validation is needed.

Similarly, education level showed a trend: those with primary or no formal education had increased odds of traditional provider use, with an odds ratio of 2.11 (95% CI: 1.01-4.43), p = 0.047, indicating statistical significance.

The C allele of rs10168266 also showed a trend towards increased frequency in ANA-positive patients (P = 0.047), although the lower limit of the 95% CI for the OR (0.999–4.019) was close to 1, which hindered achieving strict statistical significance.

In this analysis the LIBERTY and SCIENCE groups showed a trend towards reduced Anti-mask Belief that did not survive multiple comparisons correction (LIBERTY: t(587) = − 2.475, p = 0.047, SCIENCE: t(587) = − 2.537, p = 0.04).

Additionally, despite BMS patients with clinically significant OC symptoms showed a trend toward worse outcomes in sleep quality, as indicated by higher PSQI scores (median 9 [7.5–10] vs. 8 [ 6 – 10 ], p = 0.047) compared with BMS patients without clinically relevant OC symptoms; this difference was not statistically significant.

47.8%, p = 0.005) and showed a trend towards lower valproic acid use (21.7% vs. 29.6%, p = 0.047), but more likely to receive antidepressants (53.8% vs. 39.5%, p < 0.001), benzodiazepines (39.9% vs. 26.6%, p < 0.001), and gabapentinoids (8.5% vs. 4.5%, p < 0.001).

Furthermore, glutamic acid (Glu, p = 0.059), glucose 1/6-phosphate (G1P/G6P, p < 0.100), and citric acid ( p = 0.091) showed a trend of higher levels in the DYS group than in the None group, while succinic acid was at a lower level ( p = 0.047) ( Table 3 ).

Yet, IH patients had higher BMI (U = 4899.5, p < 0.001), they showed a trend towards more depression (U = 459.0, p = 0.047) and had more anxiety symptoms (U = 3332.0, p < 0.001) compared to healthy controls. 27 (36%) IH patients in our sample were overweight (25 ≤ BMI < 30), 11 (15%) were clinically obese (BMI > 30), 6 had clinical depression (suggested cut-off at 23 on the BDI-II) 36 and 10 had clinical anxiety (suggested cut-off at 16 on the BAI) 31 .

Trunk flexor and extensor strength was lower in LBP patients, with a reduced trunk flexor/trunk extensor ratio (0.77±0.20 vs 0.96±0.16, P <0.001); hip flexor/extensor ratios showed a trend toward imbalance (left hip flexor/hip extensor: 0.60±0.15 vs 0.67±0.12, P =0.047).

Experimental mice showed significant plasticity between morning (M) and evening (E) sessions ( Figure 2C and D ; one-way RM ANOVA, F (1.333,12) = 25.53, p = .0001; post hoc ABCD (M)—ABCD (E): p = .0010; ABCD (M)—DCBA (E): p = .0013; ABCD (E)—DCBA (E): p = .0105), while control mice showed a trend towards slightly increased VEP magnitude ( Figure 2C and D ; one-way RM ANOVA, F (1.936,17.42) = 3.690, p = .0473, post hoc ABCD (M1)—ABCD (M2): p = .0611; ABCD (M)—DCBA (E): p = .1161; ABCD (E)—DCBA (E): p = .9622).

The P1 implicit time of ring 1 on mfERG showed a trend of shortening after alcohol administration (37.9 ± 1.0; 37.2 ± 1.5; P = 0.048).

TRANSFER OF TDT TRAINING The results of the FrACT, analyzed with paired t -tests, showed a trend toward improvement of the Vernier task [ t (11) = 2.22; p = 0.048, not corrected for multiple comparisons; otherwise p = 0.2, Bonferroni corrected] in the patient group (see Figure 5 ).

Sensitivity was significantly higher with the dual modality than the single modality ( p < 0.016), while the triple modality showed a trend toward higher sensitivity ( p = 0.048).

The short allele of the 5-HTTLPR genetic variant showed a trend towards being more common in patients not using triptans (bi-allelic: P = 0.048, tri-allelic: P = 0.158) (Table 2 ).

Ripple duration also showed a trend-level main effect of task ( F (1,60) = 3.186, p = 0.048, uncorrected), with longer durations during rest compared with typing periods by 1.336 ms ( β = 1.336, SE = 0.640, t = 2.087, p = 0.123) and the CTL task by 1.526 ms ( β = 1.526, SE = 0.685, t = 2.227, p = 0.089).

The relatively rare U5 sub-clade and its defining polymorphism m.13617T>C showed a trend for association with stroke risk only with the logistic regression test (OR = 2.17, 95%CI = 1.01–4.67, p = 0.048, and OR = 2.18; 95%CI = 1.01–4.70, p = 0.047, respectively).

The NSABP B-42 trial, which randomized patients after five years of tamoxifen or AI to another five years of letrozole or placebo, showed a trend toward improved DFS at seven years (84.7% vs. 81.3%, HR 0.85, p = 0.048).

Nutritional markers showed a trend toward improvement, with a significant gain in body weight from 47.2 to 48.6 kg ( p = 0.048).

The CCI showed a trend toward increased risk in unadjusted analysis (HR: 1.03 per point, 95%CI: 1.00-1.07; P = 0.048) but was not significant after adjustment ( P = 0.161).

The 35 patients not receiving prophylaxis showed a trend of a higher risk of developing PJP ( p = 0.0483) when the cumulative prednisolone dose was increased.

In the HPV-evaluable subset ( n = 132), HPV-negative oropharyngeal squamous cell carcinoma (SCC) showed a trend toward worse median OS compared with non-oropharyngeal SCC (14.8 versus 30.0 months, P = 0.0488).

Compared with the reference group under 35 years of age, people aged 51–65 years ( β = 0.31, 95% CI [0.17, 0.44], p < 0.001) and 66 years and older ( β = 0.50, 95% CI [0.37, 0.64], p < 0.001) had significantly more severe COVID-19, while the group 36–50 years showed a trend toward more severe disease ( β = 0.13, p = 0.049).

The analysis revealed no significant differences in the proximity of CD3+CD+, CD3+CD8+, except for CD3+CD4+ T cells, which showed a trend toward reduced infiltration near tumour cells after FFX alone compared to the No_NAT group (p = 0.049).

Finally, CX3CL1 rs170361 showed a trend towards association with smaller cIMT ( p = 0.049, β = −0.05).